Pancreatic Cancer Research

ResearcherBeth Israel Deaconess Medical CenterActive in the last 2 years

Limor Appelbaum

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9753-0408; OpenAlex author ID A5073354805. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 0, last author 2)
Trials
2 (principal investigator on 2)
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 trial · 2023: 1 paper, 1 trial · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Prospective Population-Scale Validation of an Electronic Health Record–Based Model for Pancreatic Cancer Risk Last author DOI 10.64898/2026.04.11.26350318↗
  2. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. Last author DOI 10.1016/j.ebiom.2023.104888↗
  3. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study. Co-author DOI 10.1016/j.ejca.2020.10.019↗

Trials 2

  1. Prospective Validation of an EHR-based Pancreatic Cancer Risk Model Principal investigator NCT05973331↗
  2. Panc CA Risk Model & Biomarker Testing In High-Risk Cohort Principal investigator NCT05287347↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martin Rinard · 3 shared papers, 2021–2026 · strength 0.59
  2. Kai Jia · 2 shared papers, 2023–2026 · strength 0.47
  3. Eric Lahtinen · 1 shared paper, 2026 · strength 0.28
  4. Mandeep Sawhney · 1 shared paper, 2026 · strength 0.28
  5. Harvey J. Mamon · 1 shared paper, 2021 · strength 0.11
  6. Sebastien Haneuse · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.